Early intervention in patients with SSc can help modify disease progression prior to the occurrence of irreversible organ damage.

A new study reveals that the next generation of blockchain defenses will not rely on fixed rules alone but on adaptive, learning-based systems capable of evolving alongside intelligent adversaries.

The authors of a new study 1 emphasized the clear visual benefits that low-vision patients experience during low-vision ...

Company to wind down the GOBLET gastrointestinal study to focus on registration path in the U.S.With sufficient cash on hand to execute near-term ...

Detailed price information for Inhibikase Therapeutics Inc (IKT-Q) from The Globe and Mail including charting and trades.

A "promising lead" may move the field into developing effective interventions, NIA directo ...

We are grateful for the collaborative feedback from FDA on the Gemini program, which provides us a clear and expedient path forward for seeking approval of Gemini as a treatment for AKI,” said, James ...

AdvanCell, a clinical-stage radiopharmaceutical company developing innovative targeted alpha therapies for cancer, today announced the novel Phase 2 design of the ongoing TheraPb clinical trial of ...

By Rhett Ayers Butler Conservation has never lacked ideas. Protected areas, payments for ecosystem services, community management, certification schemes, and public campaigns have all been promoted as ...

A simple brain-training program that sharpens how quickly older adults process visual information may have a surprisingly powerful long-term payoff. In a major 20-year study of adults 65 and older, ...

NSCLC remains the leading cause of cancer-related mortality worldwide, with EGFR mutations being a critical driver in approximately 10-15% of lung adenocarcinomas in Western populations, and up to 40% ...